Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Other Non Operating Income (2016 - 2025)

Standard Biotools (LAB) has disclosed Other Non Operating Income for 16 consecutive years, with -$434000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to -$434000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $29.5 million, a 10.45% increase, with the full-year FY2024 number at $25.2 million, up 1712.58% from a year prior.
  • Other Non Operating Income was -$434000.0 for Q3 2025 at Standard Biotools, down from $3.9 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $26.1 million in Q4 2024 to a low of -$1.3 million in Q3 2023.
  • A 5-year average of $3.3 million and a median of $315000.0 in 2021 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: plummeted 1244.23% in 2022, then skyrocketed 2272.88% in 2024.
  • Standard Biotools' Other Non Operating Income stood at -$52000.0 in 2021, then tumbled by 1244.23% to -$699000.0 in 2022, then skyrocketed by 257.22% to $1.1 million in 2023, then surged by 2272.88% to $26.1 million in 2024, then crashed by 101.66% to -$434000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Other Non Operating Income are -$434000.0 (Q3 2025), $3.9 million (Q1 2025), and $26.1 million (Q4 2024).